JMA Journal

We are pleased to announce the launch of our new website for the JMA Journal !

Editors' Choices

Immunoglobulin G4-related disease (IgG4-RD) is a recently established systemic disease that is characteristically associated with elevated serum immunoglobulin G4 (IgG4) levels and ... show more
Shigeyuki Kawa

Introduction: In patients with Kawasaki disease (KD), who later develop coronary artery lesions (CALs), several inflammatory cytokines are reportedly higher than in patients without CALs. ... show more
Yutaro Tomobe, Osamu Nomura, Yoshihiko Morikawa, Nobuaki Inoue, Hiroshi Sakakibara, and Masaru Miura

Gene therapy has a complicated history. Some early trials resulted in catastrophes, including subjects’ deaths. In 2003, the world’s first gene therapy product (GTP) was approved in China. More recently, EU and US regulators have successively ... show more
Tetsuya Ishii


March 4, 2019
JMA Journal Volume 2, Issue 1 is available.

Aims and Scope

The JMA Journal is the official peer-reviewed scientific journal of the Japan Medical Association and the Japanese Association of Medical Sciences. The journal publishes review articles, original research articles, clinical trials, guidelines, opinions, short communications, images, case reports, letters to the editor. The JMA Journal is broadly international both in its perspective and the country of origin of the authors it publishes. The journal’s remit, through the publication of high-quality research, is to contribute to the global improvement of medical standards. The JMA Journal accepts articles related to medical science and medical care including clinical and basic medical science as well as public health. The journal also welcomes non-clinical studies such as health policy and opinion. All unsolicited articles receive a full and extensive peer review by recognized subject experts.